AU Patent

AU2019297409B2 — PqsR inverse agonists

Assigned to Helmholtz Zentrum fuer Infektionsforschung HZI GmbH · Expires 2022-12-01 · 3y expired

What this patent protects

The present invention relates to a compound according to general formula (I), which acts as an inhibitor of PqsR (the currently only known receptor for the

USPTO Abstract

The present invention relates to a compound according to general formula (I), which acts as an inhibitor of PqsR (the currently only known receptor for the

Drugs covered by this patent

Patent Metadata

Patent number: AU2019297409B2
Jurisdiction: AU
Classification: —
Expires: 2022-12-01
Drug substance claim: No
Drug product claim: No
Assignee: Helmholtz Zentrum fuer Infektionsforschung HZI GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.